BiotechTube
Home/Pipeline/LUNABELL® LD

LUNABELL® LD

Not specified

DevelopmentIn development

Key Facts

Indication
Not specified
Phase
Development
Status
In development
Company
Nobelpharma

About Nobelpharma

Japanese pharmaceutical company developing critical but neglected drugs and medical devices for rare diseases and pediatric conditions.

View full company profile

Therapeutic Areas

Rare DiseasePediatric Sleep Disorders

Other Not specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved